Dupixent kicks off 2023 as top pharma brand for ad impressions

Dupixent started 2023 the way it ended 2022: at the top.

The severe asthma treatment had the largest impressions share of voice (SOV) among Rx and over-the-counter pharma brands in January, totaling an SOV of 5.42%.